Skip to main content
. 2009 Oct 13;27(35):6006–6011. doi: 10.1200/JCO.2009.23.7545

Table 3.

Toxicity

Toxicity % of Patients by Toxicity Grade
Grade 3 Grade 4
Hematologic
    Anemia 3.1 1.6
    Leukocytes 20.3 9.4
    Lymphopenia 0 1.6
    Neutropenia 12.5 45.3
    Thrombocytopenia 9.4 4.7
    Febrile neutropenia 4.7 3.1
Nonhematologic
    Sinus bradycardia 1.6 0
    Hypotension 0 1.6
    LV diastolic dysfunction 1.6 0
    Fatigue/weakness 14.1 0
    Anorexia 1.6 0
    Dehydration 4.7 0
    Diarrhea 6.3 0
    Mucositis 1.6 0
    Nausea/vomiting 6.3 0
    Infection 1.6 0
    Hypocalcemia 1.6 1.6
    Hyponatremia 9.4 1.6
    Hypokalemia 1.6 0
    Ataxia/walking 3.1 0
    Dizziness 1.6 0
    Dyspnea 0 1.6
    Musculoskeletal 7.8 0
Bevacizumab associated
    Hypertension 7.8 0
    Cardiac ischemia 0 1.6
    Pulmonary hemorrhage 1.6 0
    Abdominal hemorrhage 1.6 0
    Epistaxis 9.4 0
    Thrombosis/embolism 0 1.6

NOTE. Total number of patients = 64. Two grade 5 toxicities occurred: one patient experienced multiorgan failure, and one patient experienced lung infection and grade 3 to 4 neutropenia.

Abbreviation: LV, left ventricle.

HHS Vulnerability Disclosure